Home / Resources / Preclinical resources

临床前

最新资源

AI in Alzheimer’s drug development: Where do disease-modifying interventions go from here?

AI in Alzheimer’s drug development: Where do disease-modifying interventions go from here?

Seeing is Understanding: Best Practices for Visualizing Nonclinical Study Data

Seeing is Understanding: Best Practices for Visualizing Nonclinical Study Data

Certara Solutions to Transform Drug Discovery and Development for Good

Certara 革新药物研发解决方案：长效变革，普惠未来

事实资料表

精选资源

Transform PK/PD Workflows with Automation and Integration

通过自动化与集成革新 PK/PD 工作流程

Upcoming preclinical webinars

网络研讨会

安全第一：揭示化合物筛选数据中的临床风险

2026 年 2 月 10 日 – 10am - 11am ET

网络研讨会

Explore Smarter, Faster PK/PD with Phoenix

2026 年 2 月 10 日 – 10-11 AM ET/CET/JST

网络研讨会

Accelerate Decisions with Certara IQ™: Scalable, AI-Driven QSP for Drug Development

Feb 12, Apr 28 – 10:00-11:00am

Latest preclinical blogs

All Preclinical - Blog

药物开发中 PK/PD 建模的机器学习

美国 FDA MIDD 配对试点计划如何帮助赞助商

Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis

揭秘临床 DDI 研究：精准测量代谢产物

细胞疗法开发的主要考虑因素

支持生物等效性和仿制药审批的 PBPK 建模

在以下活动中与我们的专家会面

16th Annual World ADC London 2026

February 23 - 26, 2026

ASCPT 2026 Annual Meeting

March 4 - 6, 2026 – Denver, CO

ACDM 2026

March 15 - 17, 2026 – Berlin, Germany – Booth 13

All preclinical resources

AI in Alzheimer’s drug development: Where do disease-modifying interventions go from here?

Central Nervous System (CNS), Certara Products - Certara IQ, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Blog

Seeing is Understanding: Best Practices for Visualizing Nonclinical Study Data

Certara Products - SEND Explorer, Guide

Leveraging the full potential of PBPK models to accelerate drug development

Certara Products - Simcyp, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation - PBPK, Webinar

Portfolio Prioritization for Large and Small Pharma Using Early-Stage Biosimulation

Modeling and Simulation, Modeling and Simulation - QSP, Webinar

Quantitative Systems Pharmacology Conference

Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Conference

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Webinar

Certara 革新药物研发解决方案：长效变革，普惠未来

事实资料表

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

Biologics, Certara Products, Certara Products - Certara IQ, Certara Products - Phoenix, Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

通过自动化与集成革新 PK/PD 工作流程

Certara Products - Phoenix, Blog

安全第一：揭示化合物筛选数据中的临床风险

Certara Products, Drug Development, Drug Safety, Model Informed Drug Development, Webinar

Fierce BIO

Accelerate Decisions with Certara IQ™: Scalable, AI-Driven QSP for Drug Development

Modeling and Simulation - QSP, Webinar

1
2
3
……
65
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software